Every US company we alert on
5,765 US-listed companies, ranked by market cap. Open any company to see every SEC filing alert we sent for it: 8-K material events, deals, capital raises, results, leadership changes and insider trades.
Sector
| # | Company | Sector | Market cap | Alerts | Latest |
|---|---|---|---|---|---|
| 3198 | Leef Brands Inc.OTC: LEEEF | Life Sciences | $47.8M | 2 | Insider BuyingOct 2, 2026 |
| 3204 | Actinium Pharmaceuticals, Inc.NYSE: ATNM | Life Sciences | $46.8M | 1 | Executive CompensationOct 15, 2026 |
| 3205 | Annovis Bio, Inc.NYSE: ANVS | Life Sciences | $46.5M | 7 | Financial ResultsNov 13, 2026 |
| 3207 | Oncolytics Biotech IncNASDAQ: ONCY | Life Sciences | $46.3M | 10 | Financial ResultsNov 13, 2026 |
| 3211 | iBio, Inc.NASDAQ: IBIO | Life Sciences | $45.4M | 6 | Clinical Trial DataNov 16, 2026 |
| 3212 | Milestone Pharmaceuticals Inc.NASDAQ: MIST | Life Sciences | $45.4M | 3 | Financial ResultsNov 13, 2026 |
| 3213 | Cannaisseur Group Inc.OTC: TCRG | Life Sciences | $45.3M | 1 | Financial ResultsNov 13, 2026 |
| 3216 | Nomad Power Solutions, Inc.NASDAQ: NMAD | Life Sciences | $45.1M | 5 | Business UpdateNov 16, 2026 |
| 3222 | Talphera, Inc.NASDAQ: TLPH | Life Sciences | $44.7M | 2 | Financial ResultsNov 12, 2026 |
| 3236 | Pliant Therapeutics, Inc.NASDAQ: PLRX | Life Sciences | $43M | 2 | Financial ResultsNov 12, 2026 |
| 3240 | Impact Biomedical Inc.NYSE: IBO | Life Sciences | $42.4M | 5 | Financial ResultsNov 9, 2026 |
| 3242 | LeonaBio, Inc.NASDAQ: LONA | Life Sciences | $42.2M | 2 | Insider BuyingOct 28, 2026 |
| 3246 | Elicio Therapeutics, Inc.NASDAQ: ELTX | Life Sciences | $41.9M | 4 | Shareholder MeetingNov 13, 2026 |
| 3247 | Gain Therapeutics, Inc.NASDAQ: GANX | Life Sciences | $41.9M | 5 | Financial ResultsNov 10, 2026 |
| 3251 | Connect Biopharma Holdings LtdNASDAQ: CNTB | Life Sciences | $41.5M | 4 | Financial ResultsNov 16, 2026 |
| 3255 | Dogwood Therapeutics, Inc.NASDAQ: DWTX | Life Sciences | $40.5M | 3 | Financial ResultsNov 6, 2026 |
| 3256 | Tevogen Inc.NASDAQ: TVGN | Life Sciences | $40.5M | 5 | Financial ResultsNov 16, 2026 |
| 3257 | Aldeyra Therapeutics, Inc.NASDAQ: ALDX | Life Sciences | $40.4M | 4 | Insider BuyingNov 13, 2026 |
| 3263 | ImageneBio, Inc.NASDAQ: IMA | Life Sciences | $39.9M | 2 | Financial ResultsNov 9, 2026 |
| 3269 | Instil Bio, Inc.NASDAQ: TIL | Life Sciences | $39M | 2 | Financial ResultsNov 16, 2026 |
| 3285 | Caribou Biosciences, Inc.NASDAQ: CRBU | Life Sciences | $38.1M | 3 | Financial ResultsNov 5, 2026 |
| 3288 | Biomea Fusion, Inc.NASDAQ: BMEA | Life Sciences | $37.8M | 4 | Financial ResultsNov 10, 2026 |
| 3290 | Serina Therapeutics, Inc.NYSE: SER | Life Sciences | $37.7M | 3 | Financial ResultsNov 12, 2026 |
| 3291 | Exozymes Inc.NASDAQ: EXOZ | Life Sciences | $37.7M | 4 | Financial ResultsNov 13, 2026 |
| 3299 | Grace Therapeutics, Inc.NASDAQ: GRCE | Life Sciences | $36.8M | 9 | Financial ResultsNov 12, 2026 |
| 3313 | OS Therapies IncNYSE: OSTX | Life Sciences | $35.6M | 3 | Business UpdateNov 12, 2026 |
| 3316 | Telomir Pharmaceuticals, Inc.NASDAQ: TELO | Life Sciences | $35.4M | 5 | Financial ResultsNov 6, 2026 |
| 3326 | Kalaris Therapeutics, Inc.NASDAQ: KLRS | Life Sciences | $34.8M | 2 | Financial ResultsNov 10, 2026 |
| 3329 | Rein Therapeutics, Inc.NASDAQ: RNTX | Life Sciences | $34.5M | 2 | Clinical Trial DataNov 16, 2026 |
| 3357 | Nanoviricides, Inc.NYSE: NNVC | Life Sciences | $31.7M | 1 | Executive CompensationSep 29, 2026 |
| 3366 | NextCure, Inc.NASDAQ: NXTC | Life Sciences | $30.6M | 7 | Insider BuyingNov 13, 2026 |
| 3373 | Black Hawk Acquisition CorpNASDAQ: BKHA | Life Sciences | $29.9M | 4 | Other 8-K FilingOct 23, 2026 |
| 3376 | ProMIS Neurosciences Inc.NASDAQ: PMN | Life Sciences | $29.8M | 5 | Financial ResultsNov 12, 2026 |
| 3381 | Inmune Bio, Inc.NASDAQ: INMB | Life Sciences | $29.3M | 4 | Financial ResultsNov 5, 2026 |
| 3386 | Scynexis IncNASDAQ: SCYX | Life Sciences | $29M | 3 | Financial ResultsNov 5, 2026 |
| 3390 | BriaCell Therapeutics Corp.NASDAQ: BCTX | Life Sciences | $28.8M | 1 | Financial ResultsOct 28, 2026 |
| 3397 | Pelthos Therapeutics Inc.NYSE: PTHS | Life Sciences | $28.1M | 7 | Financial ResultsNov 12, 2026 |
| 3399 | Aardvark Therapeutics, Inc.NASDAQ: AARD | Life Sciences | $27.6M | 5 | Financial ResultsNov 13, 2026 |
| 3404 | Rockwell Medical, Inc.NASDAQ: RMTI | Life Sciences | $27.2M | 3 | Financial ResultsNov 12, 2026 |
| 3411 | Mira Pharmaceuticals, Inc.NASDAQ: MIRA | Life Sciences | $26.5M | 5 | Clinical Trial DataNov 16, 2026 |
| 3417 | Adicet Bio, Inc.NASDAQ: ACET | Life Sciences | $25.7M | 4 | Leadership ChangeNov 13, 2026 |
| 3419 | Metagenomi Therapeutics, Inc.NASDAQ: MGX | Life Sciences | $25.7M | 4 | Investor PresentationNov 16, 2026 |
| 3422 | Marimed Inc.OTC: MRMD | Life Sciences | $25.4M | 4 | Financial ResultsNov 13, 2026 |
| 3424 | Abvc Biopharma, Inc.NASDAQ: ABVC | Life Sciences | $25.4M | 2 | Financial ResultsNov 10, 2026 |
| 3426 | Bio Essence CorpOTC: BIOE | Life Sciences | $25.3M | 2 | Financial ResultsNov 13, 2026 |
| 3427 | CervoMed Inc.NASDAQ: CRVO | Life Sciences | $25.3M | 8 | Clinical Trial DataNov 16, 2026 |
| 3436 | Incannex Healthcare Inc.NASDAQ: IXHL | Life Sciences | $24.2M | 1 | Financial ResultsNov 12, 2026 |
| 3438 | BeyondSpring Inc.NASDAQ: BYSI | Life Sciences | $24M | 7 | Financial ResultsNov 16, 2026 |
| 3442 | Filana Therapeutics, Inc.NASDAQ: FLNA | Life Sciences | $23.6M | 8 | Leadership ChangeNov 12, 2026 |
| 3444 | Transcode Therapeutics, Inc.NASDAQ: RNAZ | Life Sciences | $23.4M | 4 | Other 8-K FilingOct 28, 2026 |
| 3446 | Earth Science Tech, Inc.OTC: ETST | Life Sciences | $22.9M | 2 | Financial ResultsNov 9, 2026 |
| 3460 | Natural Alternatives International IncNASDAQ: NAII | Life Sciences | $21.4M | 1 | Financial ResultsNov 13, 2026 |
| 3467 | TherapeuticsMD, Inc.NASDAQ: TXMD | Life Sciences | $20.9M | 2 | Financial ResultsNov 13, 2026 |
| 3477 | IGC Pharma, Inc.NYSE: IGC | Life Sciences | $20.4M | 1 | Financial ResultsNov 6, 2026 |
| 3480 | Shuttle Pharmaceuticals Holdings, Inc.NASDAQ: SHPH | Life Sciences | $20.2M | 1 | Other 8-K FilingSep 16, 2026 |
| 3481 | Celularity IncNASDAQ: CELU | Life Sciences | $20.1M | 5 | PartnershipOct 29, 2026 |
| 3486 | Healthy Extracts Inc.OTC: HYEX | Life Sciences | $19.9M | 3 | Loan & DebtNov 17, 2026 |
| 3488 | Aytu Biopharma, IncNASDAQ: AYTU | Life Sciences | $19.8M | 4 | Financial ResultsNov 16, 2026 |
| 3493 | Provectus Biopharmaceuticals, Inc.OTC: PVCT | Life Sciences | $19.3M | 1 | Financial ResultsNov 10, 2026 |
| 3494 | Atossa Therapeutics, Inc.NASDAQ: ATOS | Life Sciences | $19.3M | 5 | Financial ResultsNov 10, 2026 |
| 3502 | Cocrystal Pharma, Inc.NASDAQ: COCP | Life Sciences | $18.8M | 1 | Financial ResultsNov 16, 2026 |
| 3512 | BioStem Technologies, Inc.NASDAQ: BSEM | Life Sciences | $18.4M | 5 | Earnings CallNov 12, 2026 |
| 3514 | Lipocine Inc.NASDAQ: LPCN | Life Sciences | $18.4M | 10 | Insider BuyingNov 13, 2026 |
| 3515 | Pasithea Therapeutics Corp.NASDAQ: KTTA | Life Sciences | $18.4M | 3 | Clinical Trial DataNov 16, 2026 |
| 3516 | Wintergreen Acquisition Corp.NASDAQ: WTG | Life Sciences | $18.2M | 2 | Loan & DebtOct 28, 2026 |
| 3517 | Edesa Biotech, Inc.NASDAQ: EDSA | Life Sciences | $18.2M | 4 | Regulatory ApprovalNov 17, 2026 |
| 3540 | Estrella Immunopharma, Inc.NASDAQ: ESLA | Life Sciences | $16.7M | 2 | Financial ResultsNov 16, 2026 |
| 3546 | Actuate Therapeutics, Inc.NASDAQ: ACTU | Life Sciences | $16.2M | 4 | Financial ResultsNov 13, 2026 |
| 3556 | Acumen Pharmaceuticals, Inc.NASDAQ: ABOS | Life Sciences | $15.6M | 5 | Business UpdateNov 5, 2026 |
| 3564 | Context Therapeutics Inc.NASDAQ: CNTX | Life Sciences | $15.2M | 2 | Financial ResultsNov 10, 2026 |
| 3567 | Bolt Biotherapeutics, Inc.NASDAQ: BOLT | Life Sciences | $15.1M | 8 | Financial ResultsNov 13, 2026 |
| 3577 | Tvardi Therapeutics, Inc.NASDAQ: TVRD | Life Sciences | $14.7M | 2 | Financial ResultsNov 13, 2026 |
| 3579 | Citius Pharmaceuticals, Inc.NASDAQ: CTXR | Life Sciences | $14.5M | 2 | Clinical Trial DataNov 4, 2026 |
| 3582 | Seres Therapeutics, Inc.NASDAQ: MCRB | Life Sciences | $14.4M | 3 | Financial ResultsNov 4, 2026 |
| 3589 | Allarity Therapeutics, Inc.NASDAQ: ALLR | Life Sciences | $14M | 8 | Loan & DebtNov 17, 2026 |
| 3592 | Inhibitor Therapeutics, Inc.OTC: INTI | Life Sciences | $13.9M | 1 | Shareholder MeetingSep 18, 2026 |
| 3596 | Marker Therapeutics, Inc.NASDAQ: MRKR | Life Sciences | $13.8M | 2 | Financial ResultsNov 16, 2026 |
| 3598 | Matinas BioPharma Holdings, Inc.NYSE: MTNB | Life Sciences | $13.6M | 3 | Deal TerminationNov 3, 2026 |
| 3600 | Synlogic, Inc.OTC: SYBX | Life Sciences | $13.5M | 1 | Financial ResultsNov 12, 2026 |
| 3602 | Neuphoria Therapeutics Inc.NASDAQ: NEUP | Life Sciences | $13.4M | 2 | Financial ResultsNov 16, 2026 |
| 3605 | aTYR Pharma INCNASDAQ: ATYR | Life Sciences | $13.4M | 7 | Nasdaq/NYSE Compliance NoticeNov 13, 2026 |
| 3606 | Passage BIO, Inc.NASDAQ: PASG | Life Sciences | $13.3M | 2 | Financial ResultsNov 10, 2026 |
| 3611 | Jasper Therapeutics, Inc.NASDAQ: JSPR | Life Sciences | $13.1M | 11 | Financial ResultsNov 16, 2026 |
| 3613 | Kyntra Bio, Inc.NASDAQ: KYNB | Life Sciences | $13M | 3 | Financial ResultsNov 16, 2026 |
| 3615 | Pluri Inc.NASDAQ: PLUR | Life Sciences | $12.8M | 4 | Financial ResultsNov 12, 2026 |
| 3616 | Dyadic International IncNASDAQ: DYAI | Life Sciences | $12.8M | 4 | Financial ResultsNov 13, 2026 |
| 3629 | Adia Med, Inc.OTC: ADIA | Life Sciences | $12.1M | 5 | Financial ResultsNov 16, 2026 |
| 3631 | Propanc Biopharma, Inc.NASDAQ: PPCB | Life Sciences | $12M | 2 | Financial ResultsNov 13, 2026 |
| 3632 | BioCardia, Inc.NASDAQ: BCDA | Life Sciences | $12M | 9 | Earnings CallNov 12, 2026 |
| 3635 | Aeon Biopharma, Inc.NYSE: AEON | Life Sciences | $11.8M | 5 | Financial ResultsNov 16, 2026 |
| 3636 | Lisata Therapeutics, Inc.NASDAQ: LSTA | Life Sciences | $11.8M | 5 | Financial ResultsNov 13, 2026 |
| 3638 | Valion Bio, Inc.NASDAQ: VBIO | Life Sciences | $11.7M | 14 | Shareholder MeetingNov 16, 2026 |
| 3642 | Senti Biosciences Holdings, Inc.NASDAQ: SNTI | Life Sciences | $11.7M | 6 | Capital RaiseNov 10, 2026 |
| 3645 | Biovie Inc.NASDAQ: BIVI | Life Sciences | $11.6M | 4 | Shareholder MeetingNov 10, 2026 |
| 3649 | Onconetix, Inc.NASDAQ: ONCO | Life Sciences | $11.5M | 6 | Shareholder MeetingNov 12, 2026 |
| 3650 | Dare Bioscience, Inc.NASDAQ: DARE | Life Sciences | $11.5M | 5 | Financial ResultsNov 16, 2026 |
| 3655 | Aspire-Lakewood Holdings, Inc.NASDAQ: ASBP | Life Sciences | $11.3M | 2 | M&A DealOct 20, 2026 |
| 3656 | Hepion Pharmaceuticals, Inc.OTC: HEPA | Life Sciences | $11.3M | 4 | Financial ResultsNov 16, 2026 |
| 3668 | Vyome Holdings, IncNASDAQ: HIND | Life Sciences | $10.7M | 1 | Financial ResultsNov 12, 2026 |
| 3671 | Scilex Holding CoNASDAQ: SCLX | Life Sciences | $10.6M | 1 | Loan & DebtSep 29, 2026 |